Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3016)
All Articles published online
|
Mar 1, 2004 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang TE, Kao CR, Lin SC, Chang WH, Chu CH, Lin J, Hsieh RK. Salvage therapy for hepatocellular carcinoma with thalidomide. World J Gastroenterol 2004; 10(5): 649-653 [PMID: PMC4716902 DOI: 10.3748/wjg.v10.i5.649] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i5/649.htm |
| Number | Citing Articles |
| 1 |
Her-Shyong Shiah, Yee Chao, Li-Tzong Chen, Tzy-Jyun Yao, Jin-Ding Huang, Jang-Yang Chang, Pei-Jer Chen, Tsai-Rong Chuang, Yung-Hsin Chin, Jacqueline Whang-Peng, Tsang-Wu Liu. Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology 2006; 58(5): 654 doi: 10.1007/s00280-006-0203-z
|
| 2 |
Peng Lv, Shelley Chireyath Paul, Yanjv Xiao, Shiquan Liu, Hesheng Luo. Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis. Mediators of Inflammation 2006; 2006(1) doi: 10.1155/MI/2006/93253
|
| 3 |
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection. Annals of Surgery 2015; 261(3): 521 doi: 10.1097/SLA.0000000000000746
|
| 4 |
Ching-Wei Chang, Tsang-En Wang, Li-Tzong Chen, Wen-Hsiung Chang, Yi-Shing Leu, Yang-Kai Fan, Yu-Jan Chan. Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: a case report and review of the literature. Medical Oncology 2008; 25(3): 264 doi: 10.1007/s12032-007-9028-9
|
| 5 |
Chapter 4: Chemotherapy and radiotherapy. Hepatology Research 2010; 40(s1): 74 doi: 10.1111/j.1872-034X.2010.00657.x
|
| 6 |
Andrew X. Zhu. Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?. The Oncologist 2006; 11(7): 790 doi: 10.1634/theoncologist.11-7-790
|
| 7 |
Chul Ju Han. Recent developments in systemic chemotherapy for hepatocellular carcinoma. The Korean Journal of Hepatology 2008; 14(1): 4 doi: 10.3350/kjhep.2008.14.1.4
|
| 8 |
Magnus Rizell, Mats Andersson, Christian Cahlin, Larsolof Hafström, Michael Olausson, Per Lindnér. Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. International Journal of Clinical Oncology 2008; 13(1): 66 doi: 10.1007/s10147-007-0733-3
|
| 9 |
Melanie Thomas. Molecular targeted therapy for hepatocellular carcinoma. Journal of Gastroenterology 2009; 44(S19): 136 doi: 10.1007/s00535-008-2252-z
|
| 10 |
Jonathan D. Schwartz, Josep M. Llovet. Molecular Targeting in Oncology. Cancer Drug Discovery and Development 2008; : 165 doi: 10.1007/978-1-59745-337-0_8
|
| 11 |
Yu-Yun Shao, Ann-Lii Cheng, Chih-Hung Hsu. Metronomic Chemotherapy. 2014; : 189 doi: 10.1007/978-3-662-43604-2_13
|
| 12 |
|
| 13 |
Domenico Ribatti, Angelo Vacca, Beatrice Nico, Domenico Sansonno, Franco Dammacco. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. Cancer Treatment Reviews 2006; 32(6): 437 doi: 10.1016/j.ctrv.2006.06.002
|
| 14 |
Shin‐Cherng Chen, Hui‐Jen Tsai, Chang‐Ming Jan, Yi‐Hui Wang, Li‐Tzong Chen. Low dose of thalidomide can be effective in advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2006; 21(12): 1868 doi: 10.1111/j.1440-1746.2006.04303.x
|
| 15 |
William Sanchez, Jayant A. Talwalkar. Palliative Care for Patients with End-Stage Liver Disease Ineligible for Liver Transplantation. Gastroenterology Clinics of North America 2006; 35(1): 201 doi: 10.1016/j.gtc.2005.12.007
|
| 16 |
Hsueh-Erh Chiou, Tsang-En Wang, Ying-Yue Wang, Hui-Wen Liu. Efficacy and safety of thalidomide in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(43): 6955-6960 doi: 10.3748/wjg.v12.i43.6955
|
| 17 |
L.‐T. CHEN, T.‐W. LIU, Y. CHAO, H.‐S. SHIAH, J.‐Y. CHANG, S.‐H. JUANG, S.‐C. CHEN, T.‐R. CHUANG, Y.‐H. CHIN, J. WHANG‐PENG. α‐fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2005; 22(3): 217 doi: 10.1111/j.1365-2036.2005.02547.x
|
| 18 |
Sang Hoon Han, Se Hoon Park, Jung Ho Kim, Jong Jun Lee, So Young Kwon, Oh Sang Kwon, Sun Suk Kim, Ju Hyun Kim, Keon Kug Kim, Yeon Ho Park, Jeong Nam Lee, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee. Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study. The Korean Journal of Internal Medicine 2006; 21(4): 225 doi: 10.3904/kjim.2006.21.4.225
|
| 19 |
David Semela, Jean-François Dufour. Angiogenesis and hepatocellular carcinoma. Journal of Hepatology 2004; 41(5): 864 doi: 10.1016/j.jhep.2004.09.006
|
| 20 |
A. Ponferrada, M. Salcedo, A. Matilla, O. Núñez, R. Bañares, E. Álvarez, G. Clemente. Heterogeneidad clínica y evolutiva del hemangioendotelioma epitelioide hepático. Gastroenterología y Hepatología 2005; 28(6): 321 doi: 10.1157/13076348
|
| 21 |
Tsang‐En WANG, Ken‐Hong LIM, Ming‐Jer HUANG. Combined thalidomide and interferon‐α for chronic hepatitis C‐related hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2007; 3(1): 52 doi: 10.1111/j.1743-7563.2006.00082.x
|
| 22 |
Stefan Sleijfer, Wim H.J. Kruit, Gerrit Stoter. Thalidomide in solid tumours: the resurrection of an old drug. European Journal of Cancer 2004; 40(16): 2377 doi: 10.1016/j.ejca.2004.07.023
|
| 23 |
Benjamin Chuah, Robert Lim, Michael Boyer, Ai-Bee Ong, Seng-Weng Wong, Hwai-Loong Kong, Michael Millward, Stephen Clarke, Boon-Cher Goh. Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma. Acta Oncologica 2007; 46(2): 234 doi: 10.1080/02841860600702076
|
| 24 |
Andrew X. Zhu, Charles S. Fuchs, Jeffrey W. Clark, Alona Muzikansky, Kerry Taylor, Susan Sheehan, Kayao Tam, Elizabeth Yung, Matthew H. Kulke, David P. Ryan. A Phase II Study of Epirubicin and Thalidomide in Unresectable or Metastatic Hepatocellular Carcinoma. The Oncologist 2005; 10(6): 392 doi: 10.1634/theoncologist.10-6-392
|
| 25 |
Lars A Ormandy, Anatol Färber, Tobias Cantz, Susanne Petrykowska, Heiner Wedemeyer, Monique Hörning, Frank Lehner, Michael P Manns, Firouzeh Korangy, Tim F Greten. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(20): 3275-3282 doi: 10.3748/wjg.v12.i20.3275
|
| 26 |
Chiun Hsu, Chiung-Nien Chen, Ann-Lii Cheng. Liver Cancer. 2009; : 277 doi: 10.1007/978-1-4020-9804-8_21
|
| 27 |
Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano, Ajay K. Nooka, Isaac I. Schnirer, Jerome B. Zeldis, James L. Abbruzzese, Thomas D. Brown. Thalidomide in the treatment of patients with hepatocellular carcinoma. Cancer 2005; 103(4): 749 doi: 10.1002/cncr.20821
|
| 28 |
Matthias Pinter, Martina Wichlas, Katharina Schmid, Christina Plank, Christian Müller, Friedrich Wrba, Markus Peck-Radosavljevic. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. European Journal of Gastroenterology & Hepatology 2008; 20(10): 1012 doi: 10.1097/MEG.0b013e3283036740
|
| 29 |
Dimitris Zacharoulis, Constantine Hatzitheofilou, Evangelos Athanasiou, Stergios Zacharoulis. Antiangiogenic strategies in hepatocellular carcinoma: current status. Expert Review of Anticancer Therapy 2005; 5(4): 645 doi: 10.1586/14737140.5.4.645
|
| 30 |
Jonathan D. Schwartz, Max Sung, Myron Schwartz, Deborah Lehrer, John Mandeli, Leonard Liebes, Alec Goldenberg, Matthew Volm. Thalidomide in Advanced Hepatocellular Carcinoma with Optional Low-Dose Interferon-α2a upon Progression. The Oncologist 2005; 10(9): 718 doi: 10.1634/theoncologist.10-9-718
|
| 31 |
Austin Duffy, Tim Greten. Developing better treatments in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2010; 4(5): 551 doi: 10.1586/egh.10.58
|